What Would (Should) CMS Do? A Debate on Options for Drug Price Negotiations
Author(s)
Daniel Ollendorf, PhD, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
Presentation Documents
This Discussion Group will focus on and feature speakers from the session What Would (Should) CMS Do? A Debate on Options for Drug Price Negotiations (Monday, May 8, 10:15am – 11:15am).
Seating is limited.
Conference/Value in Health Info
2023-05, ISPOR 2023, Boston, MA, USA
Code
119
Topic
Health Policy & Regulatory